Value Sense
POAI
Predictive Oncology Inc. (POAI)
Last Price$1.3(9.4%)
Market Cap$8,155.2K
WACC
7.3%
Cost of Equity
9.4%
Cost of Debt
0.0%
Debt to Equity
29.4%
Beta
0.8
Stock quality
4/10
Good
POAI
is 297.3% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

POAI WACC

Recent WACC calculation

as of Mar 03, 2025
Cost of Equity
% share of Total Capital
9.4%
77.3%
Risk-free rate
4.2%
Beta
1.1
Equity Risk Premium
4.6%
Country risk premium
0.0%
Cost of Debt (after-tax)
% share of Total Capital
0.0%
22.7%
Average Cost of Debt
0.0%
Effective Tax Rate
0.0%
WACC
7.3%

WACC dynamics

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

POAI Cost of Equity

Recent Cost of Equity calculation

as of Mar 03, 2025
Risk-free rate
4.2%
Beta
1.1
Equity risk premium
4.6%
Country risk premium
0.0%
Cost of Equity
9.4%

Cost of Equity dynamics

POAI vs Peer Set: Discount Rate Comparison

WACC
Cost of Equity

General

Discount rate

financials

Company name

Revenue growth

EPS growth

Net Income margin

Predictive Oncology Inc. logo
Predictive Oncology Inc.POAI
7.3%
18.2%
(64.9%)
(785.6%)
Median Peer Set
7.5%
3.4%
23.0%
10.4%
Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc.ISRG
10.5%
17.2%
27.7%
27.8%
West Pharmaceutical Services, Inc. logo
West Pharmaceutical Services, Inc.WST
8.6%
(1.9%)
(15.5%)
17.0%
Hologic, Inc. logo
Hologic, Inc.HOLX
8.5%
(0.0%)
81.1%
19.6%
Masimo Corporation logo
Masimo CorporationMASI
8.2%
0.6%
(42.5%)
4.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
7.7%
8.4%
32.2%
10.1%
ResMed Inc. logo
ResMed Inc.RMD
7.2%
10.9%
13.4%
21.8%
Alcon Inc. logo
Alcon Inc.ALC
6.8%
8.5%
182.9%
10.3%
AptarGroup, Inc. logo
AptarGroup, Inc.ATR
6.8%
2.7%
30.2%
10.5%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
5.6%
4.2%
18.3%
8.4%
Baxter International Inc. logo
Baxter International Inc.BAX
4.5%
(69.5%)
(100.0%)
(6.9%)

Explore more intrinsic value tools hub for POAI

Peter Lynch Fair Value
Margin of safety
Reverse DCF
Relative Value
DCF value calculator
Ben Graham Fair Value
Intrinsic Value
Peter Lynch charts
Earnings growth model
Earnings Power Value

FAQ

What is Predictive Oncology Inc.'s discount rate as of Mar 03, 2025?

As of Mar 03, 2025, Predictive Oncology Inc.'s discount rate is 7.29%. This rate is determined based on the weighted average cost of capital (WACC) and the cost of equity, factoring in Predictive Oncology Inc.'s capital structure and risk profile.

What is Predictive Oncology Inc.'s weighted average cost of capital (WACC)?

Predictive Oncology Inc.'s WACC as of Mar 03, 2025, is 7.29%. This value is calculated by blending the cost of debt and cost of equity, reflecting the company’s overall cost of financing its operations.

What is Predictive Oncology Inc.'s cost of equity?

Predictive Oncology Inc.'s cost of equity is 9.4%, as of Mar 03, 2025. This is the return that shareholders expect based on the stock's risk level and market conditions, used to calculate the discount rate for valuing future cash flows.